Literature DB >> 21030670

Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans.

Kanagaraj Marimuthu1, Andrew J Murton, Paul L Greenhaff.   

Abstract

Muscle mass loss accompanies periods of bedrest and limb immobilization in humans and requires rehabilitation exercise to effectively restore mass and function. Although recent evidence points to an early and transient rise in muscle protein breakdown contributing to this decline in muscle mass, the driving factor seems to be a reduction in muscle protein synthesis, not least in part due to the development of anabolic resistance to amino acid provision. Although the AKT signaling pathway has been identified in small animals as central to the regulation of muscle protein synthesis, several studies in humans have now demonstrated a disassociation between AKT signaling and muscle protein synthesis during feeding, exercise, and immobilization, suggesting that the mechanisms regulating protein synthesis in human skeletal muscle are more complex than initially thought (at least in non-inflammatory states). During rehabilitation, exercise-induced myogenesis may in part be responsible for the recovery of muscle mass. Rapid and sustained exercise-induced suppression of myostatin mRNA expression, that precedes any gain in muscle mass, points to this, along with other myogenic proteins, as being potential regulators of muscle regeneration during exercise rehabilitation in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030670     DOI: 10.1152/japplphysiol.00962.2010

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  39 in total

1.  Proteomic profiling of skeletal muscle plasticity.

Authors:  Kay Ohlendieck
Journal:  Muscles Ligaments Tendons J       Date:  2012-04-01

Review 2.  A mini review: Proteomics approaches to understand disused vs. exercised human skeletal muscle.

Authors:  Yoshitake Cho; Robert S Ross
Journal:  Physiol Genomics       Date:  2018-06-29       Impact factor: 3.107

3.  Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.

Authors:  M Invernizzi; S Carda; M Rizzi; E Grana; D F Squarzanti; C Cisari; C Molinari; F Renò
Journal:  Spinal Cord       Date:  2015-04-21       Impact factor: 2.772

4.  A transient protective effect of low-level laser irradiation against disuse-induced atrophy of rats.

Authors:  Yung-Ting Kou; Hui-Tien Liu; Chun-Yin Hou; Chuang-Yu Lin; Chung-Min Tsai; Hsi Chang
Journal:  Lasers Med Sci       Date:  2019-04-04       Impact factor: 3.161

Review 5.  Disuse-induced muscle wasting.

Authors:  Sue C Bodine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-22       Impact factor: 5.085

Review 6.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

7.  Unilateral strength training leads to muscle-specific sparing effects during opposite homologous limb immobilization.

Authors:  Justin W Andrushko; Joel L Lanovaz; Kelsey M Björkman; Saija A Kontulainen; Jonathan P Farthing
Journal:  J Appl Physiol (1985)       Date:  2017-12-14

Review 8.  Mechanistic links between oxidative stress and disuse muscle atrophy.

Authors:  Scott K Powers; Ashley J Smuder; David S Criswell
Journal:  Antioxid Redox Signal       Date:  2011-06-17       Impact factor: 8.401

9.  Electrical impedance alterations in the rat hind limb with unloading.

Authors:  J Li; A J Spieker; G D Rosen; S B Rutkove
Journal:  J Musculoskelet Neuronal Interact       Date:  2013-03       Impact factor: 2.041

10.  Comparative functional genomics of adaptation to muscular disuse in hibernating mammals.

Authors:  Vadim B Fedorov; Anna V Goropashnaya; Nathan C Stewart; Øivind Tøien; Celia Chang; Haifang Wang; Jun Yan; Louise C Showe; Michael K Showe; Brian M Barnes
Journal:  Mol Ecol       Date:  2014-11-03       Impact factor: 6.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.